XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 8,014,098 $ 1,885,628
Accounts receivable 9 455
Inventory, net 166,322 167,593
Other current assets 291,166 419,521
Total current assets 8,471,595 2,473,197
Intangible assets, net 26,028,058 28,283,208
Property and equipment, net 691,100 876,572
Other assets 348,634 208,827
Total assets 35,539,387 31,841,804
Current liabilities:    
Contract liabilities 106,502 112,555
Convertible notes payable 3,000,000
Senior secured convertible notes measured at fair value - Current 1,585,761
Other notes payable, related party 312,000 42,000
Accrued expenses and others current liabilities 738,936 1,182,283
Total current liabilities 5,743,199 1,336,838
Senior secured convertible notes measured at fair value 2,651,556
Convertible notes payable 9,000,000 3,000,000
Other notes payable, related party - noncurrent 270,000
Other long-term liabilities 83,912 135,829
Total liabilities 14,827,111 7,394,223
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding as of June 30, 2024 and December 31,2023, respectively
Common stock, $0.01 par value; 300,000,000 shares authorized as of June 30, 2024 and December 31, 2023, 7,388,674 and 4,677,787 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 73,887 46,778
 Common stock to be issued 270 shares and 162,337 shares as of June 30, 2024 and December 31, 2023, respectively 3 1,623
Additional paid-in capital 65,414,761 62,555,808
Accumulated deficit (44,395,987) (37,886,155)
Accumulated other comprehensive loss - translation adjustment (380,388) (270,473)
Total stockholders’ equity 20,712,276 24,447,581
Total liabilities and stockholders’ equity $ 35,539,387 $ 31,841,804